KR101883161B1 - Health functional food composition(pill type, paste type product) improving joint health and manufacturing method thereof - Google Patents
Health functional food composition(pill type, paste type product) improving joint health and manufacturing method thereof Download PDFInfo
- Publication number
- KR101883161B1 KR101883161B1 KR1020180036311A KR20180036311A KR101883161B1 KR 101883161 B1 KR101883161 B1 KR 101883161B1 KR 1020180036311 A KR1020180036311 A KR 1020180036311A KR 20180036311 A KR20180036311 A KR 20180036311A KR 101883161 B1 KR101883161 B1 KR 101883161B1
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- chicken
- prepared
- joint health
- concentrate
- Prior art date
Links
- 230000037231 joint health Effects 0.000 title claims abstract description 38
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 239000006187 pill Substances 0.000 title abstract description 5
- 238000004519 manufacturing process Methods 0.000 title description 24
- 230000036541 health Effects 0.000 title description 4
- 235000013376 functional food Nutrition 0.000 title description 2
- 239000000843 powder Substances 0.000 claims abstract description 101
- 241000287828 Gallus gallus Species 0.000 claims abstract description 62
- 239000012141 concentrate Substances 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 14
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 13
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 13
- 238000010438 heat treatment Methods 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 11
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 102000004190 Enzymes Human genes 0.000 claims abstract description 5
- 108090000790 Enzymes Proteins 0.000 claims abstract description 5
- 235000013330 chicken meat Nutrition 0.000 claims description 52
- 230000006872 improvement Effects 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 7
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims description 2
- 210000003746 feather Anatomy 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 abstract description 14
- 238000006911 enzymatic reaction Methods 0.000 abstract description 8
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract description 6
- 108010010803 Gelatin Proteins 0.000 abstract description 5
- 239000004365 Protease Substances 0.000 abstract description 5
- 238000001035 drying Methods 0.000 abstract description 5
- 229920000159 gelatin Polymers 0.000 abstract description 5
- 239000008273 gelatin Substances 0.000 abstract description 5
- 235000019322 gelatine Nutrition 0.000 abstract description 5
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 5
- 241000427159 Achyranthes Species 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 235000017788 Cydonia oblonga Nutrition 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 239000012295 chemical reaction liquid Substances 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 21
- 210000000988 bone and bone Anatomy 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 10
- 102000035195 Peptidases Human genes 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 240000000249 Morus alba Species 0.000 description 6
- 235000008708 Morus alba Nutrition 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 206010034203 Pectus Carinatum Diseases 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 206010003246 arthritis Diseases 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 239000008186 active pharmaceutical agent Substances 0.000 description 4
- 210000000845 cartilage Anatomy 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 210000002997 osteoclast Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 240000007472 Leucaena leucocephala Species 0.000 description 3
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 235000013345 egg yolk Nutrition 0.000 description 3
- 210000002969 egg yolk Anatomy 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000237536 Mytilus edulis Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000003056 antler Anatomy 0.000 description 2
- 210000001188 articular cartilage Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 235000020638 mussel Nutrition 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 102000010498 Receptor Activator of Nuclear Factor-kappa B Human genes 0.000 description 1
- 108010038036 Receptor Activator of Nuclear Factor-kappa B Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000012883 Tumor Necrosis Factor Ligand Superfamily Member 14 Human genes 0.000 description 1
- 108010065158 Tumor Necrosis Factor Ligand Superfamily Member 14 Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 235000021487 ready-to-eat food Nutrition 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/20—Meat products; Meat meal; Preparation or treatment thereof from offal, e.g. rinds, skins, marrow, tripes, feet, ears or snouts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
- A23L13/48—Addition of, or treatment with, enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/50—Poultry products, e.g. poultry sausages
- A23L13/52—Comminuted, emulsified or processed products; Pastes; Reformed or compressed products from poultry meat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
본 발명은 단백질분해효소 처리한 닭발 농축액과 우슬 분말, 홍화씨 분말, 오가피 분말, 두충 분말, 계지 분말, 목과 분말 및 녹각교 분말을 혼합한 약재 분말을 혼합하고 제환한 후 건조하는 단계를 포함하여 제조하는 것을 특징으로 하는 관절건강 개선용 환의 제조방법 및 상기 방법으로 제조된 관절건강 개선용 환에 관한 것이다. The present invention relates to a process for preparing a chicken broth containing proteolytic enzyme-treated chicken broth concentrate and a pharmaceutical powder comprising a mixture of a starch powder, a safflower powder, a safflower seed powder, an acacia oil powder, a mulberry powder, an egg yolk powder, a neck powder and a starch powder, A method for manufacturing a ring for improving joint health and a ring for improving joint health prepared by the method.
인체에서 관절은 두 개의 뼈가 연결된 부분으로 관절 연골로 둘러싸여 있다. 뼈는 칼슘과 인이 석회화된 단단한 조직으로 몸을 지탱하고 보호하는 중요한 역할을 하는데, 관절 연골이 손실되지 않고 건강한 상태를 유지하여 관절을 부드럽게 움직이며, 정상적인 뼈의 분해와 재형성이 일어나는 것을 건강한 관절/뼈라고 할 수 있다.In the human body, joints are the joints of two bones and are surrounded by articular cartilage. Bone is a hard, calcified tissue of calcium and phosphorus that plays an important role in supporting and protecting the body. It maintains a healthy state without loss of articular cartilage, smoothly moving joints, and normal bone breakdown and re- Joint / bone.
인체의 뼈는 매일 조금씩 분해되고, 분해된 양만큼 새로운 뼈로 채워짐으로써 항상성을 유지하는 매우 역동적인 기관이다. 뼈를 분해하는 파골세포 (Osteoclast)와 뼈를 재생하는 조골세포(Osteoblast)는 항상성을 유지하는데, RANKL(Receptor Activator of NF-κB Ligand)는 염증 전구 단백질이며 파골세포 표면 수용체 단백질이다. 뼈를 흡수하는 파골세포의 활성이 증가하게 되면, 뼈의 분해가 촉진, 뼈가 얇아지고 쉽게 부러지는 골다공증과 같은 질병이 일어나게 되며, 조골세포의 활성이 증가하게 되면, 골밀도의 증가로 뼈의 기형이나 골석화증이 일어나게 된다. 따라서 파골세포 분화와 활성의 증가는 치주염, 골다공증, 관절염 등과 같은 뼈의 파괴를 가져오게 된다.The body's bones are a very dynamic organ that breaks up every day and maintains homeostasis by being filled with new bones as much as the disassembled amount. Osteoclasts that break down bones and osteoblasts that regenerate bone maintain homeostasis. RANKL (Receptor Activator of NF-κB Ligand) is an inflammatory precursor protein and an osteoclast surface receptor protein. As the activity of osteoclasts that absorb bone is increased, bone destruction is promoted, bone becomes thin, and diseases such as osteoporosis are easily broken. When the activity of osteoblasts increases, Or bone metastasis. Thus, osteoclast differentiation and increased activity leads to bone destruction such as periodontitis, osteoporosis, arthritis, and the like.
그렇지만 현대인은 칼슘과 단백질의 부족, 호르몬의 불균형, 신체 활동량의 감소, 가공식품의 잦은 섭취 등 다양한 원인에 의해 무리가 가해져 관절/뼈의 건강을 해칠 수 있다.However, modern humans can be harmful to the health of joints / bones due to various reasons such as lack of calcium and protein, hormone imbalance, decrease of physical activity, frequent ingestion of processed foods.
닭발은 닭의 일부이며 한국을 비롯한 여러 나라에서 요리의 재료로 사용하고 있는 고단백질의 영양식품으로서, 닭발에 있는 주요한 영양 성분 중 콜라겐 성분은 젊은 여성들의 피부미용에 좋으며 골다공증, 신경통, 관절염에도 좋다. 상기 콜라겐은 동물의 뼈·연골·이·건(腱)·피부 외에 물고기의 비늘 등을 구성하는 경단백질(硬蛋白質)로서 교원질(膠原質)이라고도 한다. 섬유상 고체로 존재하고, 전자현미경으로 보면 복잡한 가로무늬 구조로 되어 있다. 물, 묽은 산, 묽은 알칼리에는 녹지 않지만 끓이면 젤라틴이 되어 용해되며 트립신 등의 단백질 분해효소의 작용은 받기 어렵고, 콜라게나아제의 작용을 받는다. 구성 아미노산은 프롤린, 옥시프롤린, 글리신, 글루탐산 등이며, 그 중에서도 다른 단백질에 존재하지 않는 옥시프롤린의 함량이 높다는 것이 특징이다.Chickenball is a high-protein nutritional food used as a cooking ingredient in Korea and other parts of Korea. Collagen is one of the major nutrients in chickens, which is good for young women's skin and is also good for osteoporosis, neuralgia and arthritis. . The collagen is also referred to as collagen (collagen) as a light protein (hard protein) constituting the scales of fish, bone, cartilage, teeth, tendons, skin in addition to the skin. It is present as a fibrous solid and has a complex horizontal pattern structure when viewed under an electron microscope. It does not dissolve in water, dilute acid and dilute alkali but when it boils, it becomes gelatin and dissolves. It is difficult to get the action of protease such as trypsin, and it is under the action of collagenase. The constituent amino acids are proline, oxyproline, glycine, glutamic acid and the like, and the content of oxyproline which is not present in other proteins is high.
또한, 닭발에는 피부나 관절을 구성하는 콜라겐 같은 단백질 외에도 중요한 맛과 영양을 좌우하는 연골이 있다. 연골의 주성분은 젤라틴으로 되어 있는데, 젤라틴은 인체 내에서 합성되지 않는 성분이기 때문에 외부에서 섭취해야 한다. 상기 젤라틴이라는 아교질은 그 속에 생리 활성화 물질인 콘드로이친(chondroitin)이라는 성분이 들어 있어 신경통과 관절염에 좋으며 노화방지에 도움을 주고 피부미용에 효과가 높으며, 연골 회복과 재생능력증진, 통증 완화에 효과적이라고 알려져 있다.In addition, chickens have cartilage, which is important for taste and nutrition, as well as proteins such as collagen that make up the skin and joints. The major component of cartilage is gelatin, which is an ingredient that is not synthesized in the body and should be ingested from the outside. The gelatin called gelatin contains chondroitin, which is a physiologically active substance, and is good for neuralgia and arthritis. It helps prevent aging, has a high effect on skin beauty, and is effective for cartilage recovery, regeneration ability, and pain relief It is known.
또한, 닭발에는 리놀레산 성분이 함유돼 지속적으로 섭취 시 심장질환뿐만 아니라 각종 혈관계 질환을 예방하고 완화하는 데 좋으며, 아연 성분을 함유하고 있어 혈당조절, 당뇨와 정력강화, 면역력 증진에 효과가 있으며, DHA, EPA 등으로 성장발육 촉진에 좋으며, 키틴 및 키토산은 혈액응고의 촉진을 통한 지혈효과에도 효능이 있다고 알려져 있다.In addition, it contains linoleic acid component, which is good for preventing and alleviating not only heart disease but also various vascular diseases during ingestion. It contains zinc ingredient and is effective for controlling blood sugar, strengthening diabetes and vigor, and improving immunity. DHA , And EPA. Chitin and chitosan are known to be effective in hemostatic effects through promotion of blood coagulation.
한국등록특허 제1594137호에는 관절건강에 도움을 주는 건강기능식품 조성물이 개시되어 있고, 한국등록특허 제1645917호에는 관절건강에 도움이 되는 한약재 및 그의 제조방법이 개시되어 있으나, 본 발명의 관절건강에 도움을 주는 한약재 환 조성물의 제조방법과는 상이하다.Korean Patent No. 1594137 discloses a health functional food composition which helps joint health, Korean Patent No. 1645917 discloses a herbal medicine useful for joint health and a manufacturing method thereof, The present invention is different from the method for producing the herbal composition for helping the herbal composition.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명의 목적은 관절건강 개선 효과가 우수한 환을 제조하기 위해, 건강 지향적 기능성 천연물 소재 선별, 전처리 및 배합비 등의 제조조건을 최적화하여 취식이 용이하면서도 관절건강 개선 증진 효과를 기대할 수 있는 새로운 형태의 환의 제조방법을 제공하는 데 있다.SUMMARY OF THE INVENTION The present invention has been made in view of the above-mentioned needs, and it is an object of the present invention to provide a method for manufacturing a ring having excellent joint health improving effect by optimizing manufacturing conditions such as sorting, pre- And a method of manufacturing a new type of ring which can expect the effect of improving joint health.
상기 과제를 해결하기 위해, 본 발명은 (1) 닭발에 물을 첨가한 후 가열하여 닭발 연화액을 제조하는 단계; (2) 상기 (1)단계의 제조한 닭발 연화액에 단백질분해효소를 첨가하여 반응시키는 단계; (3) 상기 (2)단계의 효소 반응시킨 닭발 효소 반응액을 가열한 후, 여과하고 농축하여 닭발 농축액을 제조하는 단계; (4) 우슬 분말, 홍화씨 분말, 오가피 분말, 두충 분말, 계지 분말, 목과 분말 및 녹각교 분말을 혼합하여 약재 분말을 준비하는 단계; 및 (5) 상기 (3)단계의 제조한 닭발 농축액에 상기 (4)단계의 준비한 약재 분말을 혼합한 혼합물을 제환한 후 건조하는 단계를 포함하여 제조하는 것을 특징으로 하는 관절건강 개선용 환의 제조방법을 제공한다.In order to solve the above-described problems, the present invention provides a method for producing chicken breast softening liquid, comprising the steps of: (1) adding water to a chicken breast and heating to prepare chicken breast softening liquid; (2) adding a proteolytic enzyme to the chicken's softening liquid prepared in the step (1) and reacting; (3) preparing a chicken broth concentrate by heating the chicken broth enzyme reaction solution obtained in the step (2), filtering and concentrating the chicken chicken enzyme reaction solution; (4) preparing a pharmaceutical powder by mixing mussel powder, safflower seed powder, acacia powder, mulberry powder, interlocking powder, neck and powder and starch granules; And (5) a step of mixing and concentrating a mixture obtained by mixing the chicken concentrate prepared in the step (3) with the pharmaceutical powder prepared in the step (4), and drying the mixture. ≪ / RTI >
또한, 본 발명은 상기 방법으로 제조된 관절건강 개선용 환을 제공한다.In addition, the present invention provides a ring for improving joint health produced by the above method.
본 발명의 환은 음식으로 섭취하기 번거로운 관절건강을 개선시킬 수 있는 천연물 소재 중 최적의 건강 지향적 기능성 소재를 발굴하여, 재료 특유의 풋내가 제거되고 맛과 향이 우수하고 손쉽게 섭취할 수 있는 환을 제공할 수 있다. 또한, 본 발명의 방법으로 재료들을 전처리하여 재료 특유의 떫은맛과 이취가 없어 복용이 용이하면서 유효성분을 증진시킬 수 있는 이점이 있다. 또한, 본 발명의 환을 꾸준히 섭취할 경우 관절건강 개선 효과를 줄 수 있는 건강식품으로 상온 보관이 용이하여 더욱 섭취가 간편한 즉석식 식품으로도 기대할 수 있다.The present invention relates to a method for producing a health-oriented functional material, which is capable of improving the health of joints, which is difficult to ingest as a food of the present invention, and provides an excellent taste and flavor and can be easily ingested . In addition, the method of the present invention is advantageous in that the materials can be pretreated and there is no pungent taste and odor peculiar to the material, so that it is easy to take and the effective ingredient can be enhanced. In addition, it can be expected to be a ready-to-eat food that can be easily stored at room temperature because it is a health food that can improve the joint health when the ring of the present invention is steadily ingested.
도 1은 환 추출물의 류마티스 지수 저해 효과를 비교한 그래프이다.Fig. 1 is a graph comparing the rheumatoid factor inhibitory effect of the ring extract.
본 발명의 목적을 달성하기 위하여, 본 발명은In order to achieve the object of the present invention,
(1) 닭발에 물을 첨가한 후 가열하여 닭발 연화액을 제조하는 단계;(1) adding water to chicken feet and then heating to prepare chicken broth softening liquid;
(2) 상기 (1)단계의 제조한 닭발 연화액에 단백질분해효소를 첨가하여 반응시키는 단계;(2) adding a proteolytic enzyme to the chicken's softening liquid prepared in the step (1) and reacting;
(3) 상기 (2)단계의 효소 반응시킨 닭발 효소 반응액을 가열한 후, 여과하고 농축하여 닭발 농축액을 제조하는 단계;(3) preparing a chicken broth concentrate by heating the chicken broth enzyme reaction solution obtained in the step (2), filtering and concentrating the chicken chicken enzyme reaction solution;
(4) 우슬 분말, 홍화씨 분말, 오가피 분말, 두충 분말, 계지 분말, 목과 분말 및 녹각교 분말을 혼합하여 약재 분말을 준비하는 단계; 및(4) preparing a pharmaceutical powder by mixing mussel powder, safflower seed powder, acacia powder, mulberry powder, interlocking powder, neck and powder and starch granules; And
(5) 상기 (3)단계의 제조한 닭발 농축액에 상기 (4)단계의 준비한 약재 분말을 혼합한 혼합물을 제환한 후 건조하는 단계를 포함하여 제조하는 것을 특징으로 하는 관절건강 개선용 환의 제조방법을 제공한다.(5) A process for producing a poultice for improving joint health, which comprises preparing a concentrated mixture of the chicken concentrate prepared in the step (3) and the prepared mixture of the pharmaceutical powder prepared in the step (4) .
본 발명의 관절건강 개선용 환의 제조방법에서, 상기 (1)단계의 닭발 연화액은 바람직하게는 닭발에 물을 0.8~1.2:0.8~1.2(w:v) 비율로 첨가한 후 90~110℃에서 50~70분 동안 가열하여 제조할 수 있으며, 더욱 바람직하게는 닭발에 물을 1:1(w:v) 비율로 첨가한 후 100℃에서 60분 동안 가열하여 제조할 수 있다.In the method for manufacturing a ring for improving joint health according to the present invention, the chicken meat softening liquid of step (1) is preferably added to chicken broth at a ratio of 0.8-1.2: 0.8-1.2 (w: v) For 50 to 70 minutes. More preferably, chicken broth can be prepared by adding water at a ratio of 1: 1 (w: v) and heating at 100 DEG C for 60 minutes.
또한, 본 발명의 관절건강 개선용 환의 제조방법에서, 상기 (2)단계는 바람직하게는 닭발 연화액에 단백질분해효소를 첨가하여 45~55℃에서 10~14시간 동안 반응시킬 수 있으며, 더욱 바람직하게는 닭발 연화액에 단백질분해효소를 첨가하여 50℃에서 12시간 동안 반응시킬 수 있다.In addition, in the method for producing a ring for improving joint health of the present invention, the step (2) may be carried out by adding a proteolytic enzyme to a chicken fever softening solution at 45 to 55 ° C for 10 to 14 hours, , The proteolytic enzyme may be added to the chicken meat softening solution and reacted at 50 ° C for 12 hours.
상기 단백질분해효소는 막사자임(Maxazyme) NNP DS 및 막시프로(Maxipro) BAP로, DSM Food Specialties사의 프로테아제(Protease) 일종의 효소 제품이다. 상기, 막사자임(Maxazyme) NNP DS은 바실러스 서브틸리스(Bacillus subtilis)에서 기원되며, 약산성 및 중성 pH에서 단백질을 분해하며, 180,000 PC/g의 활성을 지닌다. 또한, 상기 막시프로(Maxipro) BAP는 바실러스 리케니포미스(Bacillus licheniformis)에서 기원되며, 중성 및 약염기성 pH에서 단백질을 분해하며, 480 DAPU/g의 활성을 지닌다.The protease is Maxazyme NNP DS and Maxipro BAP, an enzyme product of DSM Food Specialties Protease. The Maxazyme NNP DS originates from Bacillus subtilis and degrades the protein at weakly acidic and neutral pHs and has an activity of 180,000 PC / g. Also, the Maxipro BAP originates from Bacillus licheniformis and degrades the protein at neutral and weak basic pH, and has an activity of 480 DAPU / g.
또한, 본 발명의 관절건강 개선용 환의 제조방법에서, 상기 (3)단계의 닭발 농축액은 바람직하게는 닭발 효소 반응액을 80~90℃에서 50~70분 동안 가열한 후, 여과하고 25~35 brix로 농축하여 제조할 수 있으며, 더욱 바람직하게는 닭발 효소 반응액을 85℃에서 60분 동안 가열한 후, 여과하고 30 brix로 농축하여 제조할 수 있다. 상기 (1) 내지 (3)단계에 거쳐 닭발 농축액을 제조하는 것이 유효성분을 다량 추출하여 관절건강 개선 용도로 더욱 효과적으로 사용할 수 있었다.In the method for producing a ring for improving joint health according to the present invention, the chicken chicken concentrate of step (3) is preferably heated at 80 to 90 ° C for 50 to 70 minutes, filtered, brix. More preferably, the chicken chicken enzyme reaction solution is heated at 85 DEG C for 60 minutes, filtered, and concentrated to 30 brix. It has been possible to produce a chicken broth concentrate through the steps (1) to (3) above by extracting a large amount of an effective ingredient and using the same more effectively for improving joint health.
또한, 본 발명의 관절건강 개선용 환의 제조방법에서, 상기 (4)단계의 약재 분말은 바람직하게는 우슬 분말 25~35 g, 홍화씨 분말 25~35 g, 오가피 분말 25~35 g, 두충 분말 25~35 g, 계지 분말 25~35 g, 목과 분말 25~35 g 및 녹각교 분말 25~35 g을 혼합하여 준비할 수 있으며, 더욱 바람직하게는 우슬 분말 30 g, 홍화씨 분말 30 g, 오가피 분말 30 g, 두충 분말 30 g, 계지 분말 30 g, 목과 분말 30 g 및 녹각교 분말 30 g을 혼합하여 준비할 수 있다.In the method for manufacturing a ring for improving joint health according to the present invention, the pharmaceutical powder of step (4) is preferably 25 to 35 g of mash powder, 25 to 35 g of safflower seed powder, 25 to 35 g of omega powder, 25 30 g of mash powder, 30 g of safflower seed powder, 30 g of acaffin powder 30-35 g, a mixture of 25-35 g of a ground powder, 25-35 g of a neck and powder and 25-35 g of a green peach granule powder, g, 30 g of mulberry powder, 30 g of the gum powder, 30 g of the neck and powder, and 30 g of the antler powder.
상기 녹각교는 녹각을 오랜시간 물로 달여서 농축하여 만든 아교질 덩어리를 의미한다. 녹각에 비해 녹각교의 형태로 가공한 후 사용하는 것이 효능이 더욱 우수한 이점이 있다.The above-mentioned diagonal bridge refers to a mass of glue formed by dewaxing and thickening the dagger for a long time. There is an advantage that it is more effective when it is used after being processed in the form of a polygonal angle bracket compared to a waxy angle.
또한, 본 발명의 관절건강 개선용 환의 제조방법에서, 상기 (5)단계는 바람직하게는 닭발 농축액 65~75 g에 약재 분말 200~220 g을 혼합한 혼합물을 제환한 후 45~55℃에서 수분 함량이 9~13%(v/w)가 되도록 건조할 수 있으며, 더욱 바람직하게는 닭발 농축액 70 g에 약재 분말 210 g을 혼합한 혼합물을 제환한 후 50℃에서 수분 함량이 11%(v/w)가 되도록 건조할 수 있다.In addition, in the method for producing a ring for improving joint health according to the present invention, the step (5) is preferably a step of adding a mixture of 200 to 220 g of the pharmaceutical powder to 65 to 75 g of chicken concentrate, (V / w). More preferably, the mixture is prepared by mixing 70 g of chicken concentrate and 210 g of a pharmaceutical powder, and the mixture is dried at 50 ° C to have a moisture content of 11% (v / w). < / RTI >
상기 (4) 및 (5)단계의 조건으로 닭발 농축액과 약재 분말을 혼합하여 제조된 환은 관절건강 개선 효과가 우수하고, 재료들의 맛이 잘 어우러지고 이취가 없어 먹기에 부담이 없는 환으로 제조할 수 있었다.The ring made by mixing chicken concentrate with the medicinal powders under the conditions of steps (4) and (5) above is excellent in improving joint health, and has a good flavor of ingredients and no odor, I could.
본 발명의 관절건강 개선용 환의 제조방법은, 보다 구체적으로는The method for producing a ring for improving joint health of the present invention, more specifically,
(1) 닭발에 물을 0.8~1.2:0.8~1.2(w:v) 비율로 첨가한 후 90~110℃에서 50~70분 동안 가열하여 닭발 연화액을 제조하는 단계;(1) adding water to the chicken leg at a ratio of 0.8-1.2: 0.8-1.2 (w: v), and heating the chicken feather at 90-110 ° C for 50-70 minutes to prepare a chicken fever softening liquid;
(2) 상기 (1)단계의 제조한 닭발 연화액에 단백질분해효소를 첨가하여 45~55℃에서 10~14시간 동안 반응시키는 단계;(2) adding the proteolytic enzyme to the chicken broth softening solution prepared in the step (1), and allowing the proteolytic enzyme to react at 45 to 55 ° C for 10 to 14 hours;
(3) 상기 (2)단계의 효소 반응시킨 닭발 효소 반응액을 80~90℃에서 50~70분 동안 가열한 후, 여과하고 25~35 brix로 농축하여 닭발 농축액을 제조하는 단계;(3) heating the reaction solution of the chicken chicken enzyme enzyme-reacted in step (2) at 80 to 90 ° C for 50 to 70 minutes, filtering and concentrating the chicken chicken concentrate to 25 to 35 brix;
(4) 우슬 분말 25~35 g, 홍화씨 분말 25~35 g, 오가피 분말 25~35 g, 두충 분말 25~35 g, 계지 분말 25~35 g, 목과 분말 25~35 g 및 녹각교 분말 25~35 g을 혼합하여 약재 분말을 준비하는 단계; 및(4) 25 ~ 35g of mash powder, 25 ~ 35g of safflower seed powder, 25 ~ 35g of ocher powder, 25 ~ 35g of mushroom powder, 25 ~ 35g of mushroom powder, 25 ~ 35g of wood powder and 25 ~ To prepare a pharmaceutical powder; And
(5) 상기 (3)단계의 제조한 닭발 농축액 65~75 g에 상기 (4)단계의 준비한 약재 분말 200~220 g을 혼합한 혼합물을 제환한 후 45~55℃에서 수분 함량이 9~13%(v/w)가 되도록 건조하는 단계를 포함할 수 있으며,(5) A mixture of 200 to 220 g of the prepared pharmaceutical powder prepared in the above step (4) is added to 65 to 75 g of the concentrate of chicken broth prepared in the above step (3), and then the moisture content at 9 to 13 % < / RTI > (v / w)
더욱 구체적으로는More specifically,
(1) 닭발에 물을 1:1(w:v) 비율로 첨가한 후 100℃에서 60분 동안 가열하여 닭발 연화액을 제조하는 단계;(1) adding water to chicken feet at a ratio of 1: 1 (w: v), and heating the chicken feet at 100 ° C for 60 minutes to prepare chicken breast softening liquid;
(2) 상기 (1)단계의 제조한 닭발 연화액에 단백질분해효소를 첨가하여 50℃에서 12시간 동안 반응시키는 단계;(2) adding a proteolytic enzyme to the chicken meat softening solution prepared in the step (1) and allowing the chicken meat softening solution to react at 50 ° C for 12 hours;
(3) 상기 (2)단계의 효소 반응시킨 닭발 효소 반응액을 85℃에서 60분 동안 가열한 후, 여과하고 30 brix로 농축하여 닭발 농축액을 제조하는 단계;(3) preparing a chicken broth concentrate by heating the chicken chicken enzyme reaction solution obtained in the step (2) above at 85 ° C for 60 minutes, filtering and concentrating the chicken broth at 30 brix;
(4) 우슬 분말 30 g, 홍화씨 분말 30 g, 오가피 분말 30 g, 두충 분말 30 g, 계지 분말 30 g, 목과 분말 30 g 및 녹각교 분말 30 g을 혼합하여 약재 분말을 준비하는 단계; 및(4) preparing a pharmaceutical powder by mixing 30 g of powdered mash powder, 30 g of safflower seed powder, 30 g of ocher powder, 30 g of mulberry powder, 30 g of guillotine powder, 30 g of neck and powder, and 30 g of antler powder. And
(5) 상기 (3)단계의 제조한 닭발 농축액 70 g에 상기 (4)단계의 준비한 약재 분말 210 g을 혼합한 혼합물을 제환한 후 50℃에서 수분 함량이 11%(v/w)가 되도록 건조하는 단계를 포함할 수 있다.(5) The mixture of 70 g of the concentrate of chicken broth prepared in the above step (3) and 210 g of the prepared medicinal powder prepared in the above step (4) was mixed to obtain a water content of 11% (v / w) at 50 ° C. Drying step.
본 발명은 또한, 상기 방법으로 제조된 관절건강 개선용 환을 제공한다.The present invention also provides a ring for improving joint health produced by the above method.
이하, 본 발명의 제조예 및 실시예를 들어 상세히 설명한다. 단, 하기 제조예 및 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 제조예 및 실시예에 한정되는 것은 아니다.Hereinafter, production examples and examples of the present invention will be described in detail. However, the following Preparation Examples and Examples are illustrative of the present invention, and the content of the present invention is not limited to the following Production Examples and Examples.
제조예Manufacturing example 1. 관절건강 환 1. Joint health circle
(1) 조분쇄한 닭발에 물을 1:1(w:v) 비율로 첨가한 후 100℃에서 1시간 동안 끓여 닭발 연화액을 제조하였다.(1) Water was added to crude chicken broth at a ratio of 1: 1 (w: v) and boiled at 100 ° C for 1 hour to prepare chicken broth softening liquid.
(2) 상기 (1)단계의 제조한 닭발 연화액을 50℃로 냉각하고, 단백질분해효소인 막사자임(Maxazyme) NNP DS 및 막시프로(Maxipro) BAP를 연화액 대비 0.3%씩 첨가한 후 12시간 동안 교반하면서 반응시켰다.(2) The chicken broth softener prepared in the above step (1) was cooled to 50 ° C, and protease enzymes Maxazyme NNP DS and Maxipro BAP were added in an amount of 0.3% Lt; / RTI > for 1 hour.
(3) 상기 (2)단계의 효소 반응시킨 닭발 효소 반응액을 85℃에서 1시간 동안 가열하여 효소를 실활시킨 후, 여과하고 30 brix로 농축하여 닭발 농축액을 제조하였다.(3) The enzyme reaction reaction of the step (2) was heated at 85 ° C for 1 hour to inactivate the enzyme, filtered, and concentrated to 30 brix to prepare chicken concentrate.
(4) 건조한 후 80 mesh로 분쇄한 우슬 분말 30 g, 홍화씨 분말 30 g, 오가피 분말 30 g, 두충 분말 30 g, 계지 분말 30 g, 목과 분말 30 g 및 녹각교 분말 30 g을 혼합하여 약재 분말을 준비하였다.(4) After drying, 30 g of powdered mash powder, 30 g of safflower seed powder, 30 g of omega-3 powder, 30 g of mushroom powder, 30 g of egg yolk powder, 30 g of neck and powder and 30 g of starch powder were mixed with 80- Were prepared.
(5) 상기 (3)단계의 제조한 닭발 농축액 70 g에 상기 (4)단계의 준비한 약재 분말 210 g을 혼합하여 혼합물을 제조하였다.(5) 210 g of the pharmaceutical powder prepared in the above step (4) was mixed with 70 g of the chicken broth concentrate prepared in the above step (3) to prepare a mixture.
(6) 상기 (5)단계의 제조한 혼합물을 제환기를 이용하여 제환한 후 50℃에서 수분 함량이 11%(v/w) 이내가 되도록 건조하였다.(6) The mixture prepared in the above step (5) was converted by using a ventilator, and dried at 50 ° C to a moisture content of 11% (v / w) or less.
비교예Comparative Example 1. 관절건강 환 1. Joint health circle
상기 제조예 1의 방법으로 관절건강 환을 제조하되, (2)단계에서 단백질분해효소로 막사자임(Maxazyme) NNP DS을 사용하지 않고, 막시프로(Maxipro) BAP를 연화액 대비 0.6%씩 첨가하여 제조된 닭발 농축액을 이용하여, 관절건강 환을 제조하였다.The joint health ring was prepared by the method of Preparation Example 1, except that Maxipro BAP was added at 0.6% to the softening solution without using Maxazyme NNP DS as a protease in step (2) Using the prepared concentrate of chicken breasts, joint health rings were prepared.
비교예Comparative Example 2. 관절건강 환 2. Joint Health Insurance
(1) 조분쇄한 닭발에 물을 1:1(w:v) 비율로 첨가한 후 121℃에서 1시간 동안 열을 가한 후 여과하고 30 brix로 농축하여 닭발 농축액을 제조하였다.(1) Water was added to crude chicken broth at a ratio of 1: 1 (w: v), and the mixture was heated at 121 ° C for 1 hour, filtered and concentrated to 30 brix to prepare chicken broth concentrate.
(2) 건조한 후 80 mesh로 분쇄한 우슬 분말 30 g, 홍화씨 분말 30 g, 오가피 분말 30 g, 두충 분말 30 g, 계지 분말 30 g, 목과 분말 30 g 및 녹각교 분말 30 g을 혼합하여 약재 분말을 준비하였다.(2) After drying, 30 g of powdered mash powder, 30 g of safflower seed powder, 30 g of omega-3 powder, 30 g of mushroom powder, 30 g of egg yolk powder, 30 g of neck and powder, Were prepared.
(3) 상기 (1)단계의 제조한 닭발 농축액 70 g에 상기 (2)단계의 준비한 약재 분말 210 g을 혼합한 혼합물을 제환기를 이용하여 제환한 후 50℃에서 수분 함량이 11%(v/w) 이내가 되도록 건조하였다.(3) A mixture of 210 g of the pharmaceutical powder prepared in the above step (2) and 70 g of the concentrate of chicken broth prepared in the above step (1) was diluted with a ventilating machine to obtain a water content of 11% (v / w).
제조예Manufacturing example 2. 관절건강에 도움이 되는 환 시제품 2. Prototype products that help joint health
(1) 상기 제조예 1의 (5)단계의 혼합물 중량 대비 N-아세틸 글루코사민(N-Acetyl glucosamine) 10%와 결정셀룰로오스, 글리세린 및 벌꿀을 혼합하여 반죽하였다.(1) 10% of N-acetyl glucosamine and crystalline cellulose, glycerin and honey were mixed and kneaded with respect to the weight of the mixture of step (5) of Preparation Example 1.
(2) 상기 (1)단계의 반죽한 반죽물을 제환기를 이용하여 제환한 후 50℃에서 수분 함량이 11%(v/w) 이내가 되도록 건조하였다.(2) The kneaded kneaded product of step (1) was dried using a ventilator, and dried at 50 ° C. to a moisture content of 11% (v / w) or less.
실시예Example 1. 닭발 전처리 조건에 따른 환의 관절염에 대한 항염증 작용 1. Anti-inflammatory effect on arthritis of the ring according to pretreatment condition of chicken leg
환 추출물에 대한 류마티스 관절염 항염증 작용을 알아보기 위해 DBA/1J 마우스(6주령 25 g, 중앙실험동물)에 6주간 투여하였다. 관절염의 유발은 제2형 콜라겐(Sigma, USA)을 2 mg/ml의 농도로 0.1M 아세트산에 녹인 후 Freund's incomplete adjuvant(Sigma, USA)에 유화시켜 만들었다. 그 후 100 ㎕를 흰쥐의 우측 족척에 피하주사하였다. 일차 주사 7일 후 다시 꼬리 밑동(tail head)에 동량을 추가 접종하였고, 대조군(control)에는 시료 대신 동량의 생리식염수를 접종하였다. 마지막 접종일로부터 21일째에 육안으로 관절주위 발적, 부종 및 팽창을 형성하는 개체를 선별하여 실험하였다. 환 추출물 투여시에는 환 추출물 500 mg/kg을 0.9% 생리식염수에 녹여 멤브레인 필터(pore size 0.2 ㎛, Whatman)로 여과한 후 1일 1회씩 6주 동안 경구 투여하였다.To investigate anti-inflammatory effects of rheumatoid arthritis on ring extracts, DBA / 1J mice (25 g, 6 weeks old, central experimental animals) were administered for 6 weeks. The induction of arthritis was induced by dissolving type 2 collagen (Sigma, USA) in 0.1 M acetic acid at a concentration of 2 mg / ml and emulsifying in Freund's incomplete adjuvant (Sigma, USA). 100 μl was then injected subcutaneously into the right foot of the rat. Seven days after the primary injection, the same amount was added to the tail head, and the control (control) was inoculated with the same amount of physiological saline instead of the sample. On the 21st day after the last inoculation, the individuals that formed periarticular redness, swelling and swelling were selected and examined. For the administration of the ring extract, 500 mg / kg of the ring extract was dissolved in 0.9% physiological saline, filtered through a membrane filter (pore size 0.2 μm, Whatman), and orally administered once a day for 6 weeks.
그 결과, 류마티스 지수는 제조예 1 및 비교예들의 환 추출물 투여군이 대조군에 비해서 낮은 수치를 보여, 이로 보아 환 추출물이 류마티스 관절염 억제 효능이 있음을 확인할 수 있었고, 그 중 제조예 1이 가장 낮은 수치를 나타내었다(도 1).As a result, the rheumatism index was lower than that of the control group in the crude extract administration group of Preparation Example 1 and Comparative Example, and thus it was confirmed that the ring extract inhibited rheumatoid arthritis, (Fig. 1).
실시예Example 2. 닭발 전처리 조건에 따른 환의 관절건강 개선 효과 평가 2. Assessment of joint health improvement effect of ring according to pretreatment condition
제조예 1과 비교예 1 및 2의 환을 가지고 관절건강 개선 효과를 평가하도록 하였다. 평가 방법은 관절에 불편함 및 통증을 느끼는 30명의 실험자를 대상으로 3개 군으로 나누어, 각각의 환을 하루에 10 g씩 매일 섭취하도록 하고, 섭취 30일 후 개선 정도를 10점 척도법으로 평가하게 하였다.The joint health improvement effect was evaluated with the rings of Preparation Example 1 and Comparative Examples 1 and 2. The evaluation method was divided into three groups of 30 subjects who felt discomfort and pain in the joints. Each group was given 10 g of the daily dose per day. After 30 days of ingestion, the degree of improvement was evaluated by a 10-point scale Respectively.
그 결과, 상기 표 1에 기재된 바와 같이, 제조예 1의 환이 비교예 1 및 2의 환과 비교하였을 때, 높은 점수를 나타내었다. 따라서, 비교예 1 및 2의 조건으로 처리된 닭발 농축액을 이용하는 것에 비해, 제조예 1의 조건으로 닭발 농축액을 제조한 후 환 제조 시 사용하는 것이 관절건강에 더 효과가 있음을 확인할 수 있었다.As a result, as shown in Table 1, the ring of Preparation Example 1 showed a high score when compared to the rings of Comparative Examples 1 and 2. Therefore, it was confirmed that using chicken broth concentrate under the conditions of Preparation Example 1 and using in broth production was more effective for joint health than the chicken broth concentrate treated under the conditions of Comparative Examples 1 and 2.
실시예Example 3. 재료 종류 및 배합비에 따른 환의 관절건강 개선 효과 평가 3. Assessment of the joint health improvement effect of the fingers according to the type of ingredients and the ratio
제조예 1의 방법으로 제조된 환, 제조예 1의 방법으로 환을 제조하되, 재료 및 배합비를 달리한 비교예 3 내지 8의 환을 가지고 관절건강 개선 효과를 평가하도록 하였다(표 2). 평가 방법은 관절에 불편함 및 통증을 느끼는 70명의 실험자를 대상으로 7개 군으로 나누어, 각각의 환을 매일 10 g씩 섭취하도록 하고, 섭취 30일 후 개선 정도를 10점 척도법으로 평가하게 하였다.The rings were prepared by the method of Preparation Example 1 and the rings of Comparative Examples 3 to 8 with different materials and compounding ratios were evaluated for the joint health improvement effect (Table 2). The subjects were divided into 7 groups. The subjects were divided into 7 groups. Each group was given 10 g of each day. After 30 days of ingestion, the degree of improvement was evaluated by a 10-point scale.
하기 표 3에 기재된 바와 같이, 제조예 1의 환이 8점 이상을 점수를 나타내어, 관절건강 개선 효과가 가장 우수한 것으로 평가되었다. 따라서, 본 발명의 약재 종류 및 배합비로 환제를 제조함으로써 복용이 간편하면서 관절 통증을 완화시켜 관절건강에 도움이 될 수 있을 것으로 판단된다.As shown in the following Table 3, a score of 8 or more of the rings of Preparation Example 1 was shown, and the joint health improvement effect was evaluated to be the most excellent. Accordingly, it is considered that the preparation of the pills according to the present invention can be easily administered, and the joint pain can be alleviated, thereby contributing to joint health.
Claims (6)
(2) 상기 (1)단계의 제조한 닭발 연화액에 막사자임(Maxazyme) 및 막시프로(Maxipro)를 첨가하여 45~55℃에서 10~14시간 동안 반응시키는 단계;
(3) 상기 (2)단계의 효소 반응시킨 닭발 효소 반응액을 80~90℃에서 50~70분 동안 가열한 후, 여과하고 25~35 brix로 농축하여 닭발 농축액을 제조하는 단계;
(4) 우슬 분말 25~35 g, 홍화씨 분말 25~35 g, 오가피 분말 25~35 g, 두충 분말 25~35 g, 계지 분말 25~35 g, 목과 분말 25~35 g 및 녹각교 분말 25~35 g을 혼합하여 약재 분말을 준비하는 단계; 및
(5) 상기 (3)단계의 제조한 닭발 농축액 65~75 g에 상기 (4)단계의 준비한 약재 분말 200~220 g을 혼합한 혼합물을 제환한 후 45~55℃에서 수분 함량이 9~13%(v/w)가 되도록 건조하는 단계를 포함하여 제조하는 것을 특징으로 하는 관절건강 개선용 환의 제조방법.(1) adding water to the chicken leg at a ratio of 0.8-1.2: 0.8-1.2 (w: v), and heating the chicken feather at 90-110 ° C for 50-70 minutes to prepare chicken broth softening liquid;
(2) adding Maxazyme and Maxipro to the chicken meat softening solution prepared in the step (1), and allowing the mixture to react at 45 to 55 ° C for 10 to 14 hours;
(3) heating the reaction solution of the chicken chicken enzyme enzyme-reacted in step (2) at 80 to 90 ° C for 50 to 70 minutes, filtering and concentrating the chicken chicken concentrate to 25 to 35 brix;
(4) 25 ~ 35g of mash powder, 25 ~ 35g of safflower seed powder, 25 ~ 35g of ocher powder, 25 ~ 35g of mushroom powder, 25 ~ 35g of mushroom powder, 25 ~ 35g of wood powder and 25 ~ To prepare a pharmaceutical powder; And
(5) A mixture of 200 to 220 g of the prepared pharmaceutical powder prepared in the above step (4) is added to 65 to 75 g of the concentrate of chicken broth prepared in the above step (3), and then the moisture content at 9 to 13 % < / RTI > (v / w), based on the total weight of the composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180036311A KR101883161B1 (en) | 2018-03-29 | 2018-03-29 | Health functional food composition(pill type, paste type product) improving joint health and manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180036311A KR101883161B1 (en) | 2018-03-29 | 2018-03-29 | Health functional food composition(pill type, paste type product) improving joint health and manufacturing method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR101883161B9 KR101883161B9 (en) | 2018-07-30 |
KR101883161B1 true KR101883161B1 (en) | 2018-07-30 |
Family
ID=63048356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180036311A KR101883161B1 (en) | 2018-03-29 | 2018-03-29 | Health functional food composition(pill type, paste type product) improving joint health and manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101883161B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102560440B1 (en) | 2022-03-28 | 2023-07-28 | 신현제 | Health functional food composition for improving joint health and manufacturing method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11147832A (en) * | 1997-11-18 | 1999-06-02 | Noevir Co Ltd | Neutrophil esterase inhibitor |
KR20070063096A (en) * | 2005-12-14 | 2007-06-19 | 한국푸디팜 주식회사 | Manufacturing method for chondroitin sulfate from feet of fowl |
KR20100092160A (en) * | 2009-02-12 | 2010-08-20 | 구미경 | Composition for preventing or treatment of arthritis and method for production thereof |
KR20130070065A (en) * | 2011-12-19 | 2013-06-27 | 이진용 | Functional herbal food and method for production thereof |
KR101578068B1 (en) * | 2015-04-08 | 2015-12-16 | 김경일 | Health supplementing food for alleviating symptoms of joint pathologies and a preparation method thereof |
KR101645917B1 (en) * | 2016-02-02 | 2016-08-12 | 양형열 | Medicinal herb and its producing method that will help joint health |
KR20170130968A (en) * | 2016-05-20 | 2017-11-29 | 주식회사 미싹바이오 | Production method of low molecular collagen peptide and food composition using this low molecular collagen peptide |
-
2018
- 2018-03-29 KR KR1020180036311A patent/KR101883161B1/en active IP Right Grant
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11147832A (en) * | 1997-11-18 | 1999-06-02 | Noevir Co Ltd | Neutrophil esterase inhibitor |
KR20070063096A (en) * | 2005-12-14 | 2007-06-19 | 한국푸디팜 주식회사 | Manufacturing method for chondroitin sulfate from feet of fowl |
KR20100092160A (en) * | 2009-02-12 | 2010-08-20 | 구미경 | Composition for preventing or treatment of arthritis and method for production thereof |
KR20130070065A (en) * | 2011-12-19 | 2013-06-27 | 이진용 | Functional herbal food and method for production thereof |
KR101578068B1 (en) * | 2015-04-08 | 2015-12-16 | 김경일 | Health supplementing food for alleviating symptoms of joint pathologies and a preparation method thereof |
KR101645917B1 (en) * | 2016-02-02 | 2016-08-12 | 양형열 | Medicinal herb and its producing method that will help joint health |
KR20170130968A (en) * | 2016-05-20 | 2017-11-29 | 주식회사 미싹바이오 | Production method of low molecular collagen peptide and food composition using this low molecular collagen peptide |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102560440B1 (en) | 2022-03-28 | 2023-07-28 | 신현제 | Health functional food composition for improving joint health and manufacturing method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR101883161B9 (en) | 2018-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105753935B (en) | Small-molecule peptides of sunflower head as well as preparation method and medical application of small-molecule peptide | |
CN108685100B (en) | Formula and preparation method of composite short peptide powder | |
JPH0745521B2 (en) | Antihypertensive agent having antihypertensive effect | |
KR20060083183A (en) | Vasodilator pharmaceutical preparation and health food composition | |
KR20100014572A (en) | Process for producing osteocalcin-containing extract | |
KR100725926B1 (en) | Feed containing garlic for chicken | |
KR20060082015A (en) | Composition for strengthening bone derived from egg | |
CN111467481A (en) | Composition for improving and/or preventing osteoarthritis and application thereof | |
KR101883161B1 (en) | Health functional food composition(pill type, paste type product) improving joint health and manufacturing method thereof | |
CN1718117A (en) | Instant drinking powder contg. black-fungus, oatmeal and spirulina, and its prepn. method | |
KR20140017932A (en) | Composition of diabetes-improving effective constituents by fermentation products of the trifoliate orange | |
KR101467539B1 (en) | MANUFACTURING METHOD OF FEED COMPOSITION FOR POULTRY CONTAINING Allium hookeri POWDER | |
CN1056503C (en) | High-nutrient biological synthetic functional health egg | |
JP3691685B2 (en) | Blood sugar level rise inhibitor | |
CN103734581A (en) | Yak lactoprotein polypeptide nutrition powder applicable to rehabilitation of people after operations and preparation method of powder | |
JPH02154693A (en) | Novel functional peptide and utilization thereof | |
CN108514109A (en) | Anaesthetize postoperative tailored version clinical nutrition formula and preparation method thereof | |
JP2021159063A (en) | Konjak functional food and method for producing the same | |
KR20230110470A (en) | A composition for the prevention or treatment of hypertension containing edible insects hydrolysates and fractions thereof | |
KR101642176B1 (en) | Composition for enhancing growth and reinforcing immunity | |
CN104012871B (en) | A kind of mantis shrimp health caring noodles and preparation method thereof | |
AU5185301A (en) | Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof | |
KR102322269B1 (en) | Calcium-collagen peptide chelate complex and method for preparing the same | |
CN108175004A (en) | It is a kind of suitable for beverage of diabetic and preparation method thereof | |
KR102085436B1 (en) | How to process food raw materials using raw silkworms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
G170 | Publication of correction |